Bayer AG Logo

Bayer AG

A global life science company with core competencies in healthcare and nutrition.

BAY | F

Overview

Corporate Details

ISIN(s):
DE0005752059 (+2 more)
LEI:
549300J4U55H3WP1XT59
Country:
Germany
Address:
Kaiser-Wilhelm-Allee 1, 51373 Leverkusen

Description

Bayer AG is a global life science company with core competencies in the fields of healthcare and nutrition. Guided by its mission "Health for all, Hunger for none," the company develops products and services to address fundamental human needs and global challenges. Its operations are divided into three main divisions: Pharmaceuticals, which focuses on prescription products; Consumer Health, which offers over-the-counter medications and supplements; and Crop Science, which provides tailored solutions for farmers including seeds, crop protection, and digital farming technologies. Bayer's activities encompass the discovery, development, manufacturing, and commercialization of its product portfolio, aiming to improve quality of life and ensure a sustainable supply of food and feed.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 10:33 English 28.7 KB
2025-12-04 11:51 English 28.4 KB
2025-11-23 16:47
Bayer Aktiengesellschaft: Bayers Asundexian Met Primary Efficacy and Safety End…
English 8.8 KB
2025-11-17 00:00
Hinweis auf Konzernabschluss vom 01.01.2025 bis zum 31.12.2025
German 5.2 KB
2025-11-17 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2026 bis zum 30.06.2026
German 5.2 KB
2025-11-17 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2025 bis zum 31.12.2025
German 5.2 KB
2025-11-12 00:00
Q3 statement / Q3 financial report 2025
English 249.4 KB
2025-09-02 12:09 English 12.6 KB
2025-08-06 00:00
Half-yearly financial report 2025
English 472.4 KB
2025-08-04 13:55 English 86.6 KB
2025-07-31 23:15
Bayer Aktiengesellschaft: Bayer upgrades currency-adjusted sales and earnings g…
English 12.2 KB
2025-07-24 14:09 English 83.7 KB
2025-07-22 11:51 English 86.3 KB
2025-07-04 07:38 English 86.4 KB
2025-06-26 15:30 English 23.5 KB

Automate Your Workflow. Get a real-time feed of all Bayer AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bayer AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bayer AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.